EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (3 days ago)
"Save the dates for OpenTox Euro 2017 Meeting" https://t.co/muWLfrAPZb on @LinkedIn
Douglas Connect (5 days ago)
RT @EU_ToxRisk: Global Summit on Regulatory Science ANVISA Brazil Sept.18-20, 2017 #Drug #FoodSafety #FDA #JRC @EFSA_EU @DouglasConn https:…
Douglas Connect (1 week ago)
Advancing reproducible regulatory science and practice #reproducibility #GSRS17 #RegulatoryScience… https://t.co/DmkFYO98kD
Douglas Connect (2 weeks ago)
RT @barryhardy: Working together on Safety Assessment - a Model for Collaboration @DouglasConn stand 41 #ToxHQ #EuroTox2017 https://t.co/Y0…
Douglas Connect (2 weeks ago)
RT @barryhardy: #Integrated #Testing #Strategy #Skin #Sensitization Application available for Evaluation #EuroTox2017 Douglas Connect stand…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com